[(99m)Tc]-Sestamibi parathyroid scintigraphy in chronic haemodialysis patients: Static and dynamic explorations

Nephrology Dialysis Transplantation

Volumn 15, Issue 8, 2000, Pages 1201-1206

  Olaizola, Ines ^a   Zingraff, Johanna ^b   Heuguerot, Carlos ^a   Fajardo, Laura ^a   Léger, Aubène ^c   Lopez, Juan ^a   Acuña, Gonzalo ^a   Petraglia, Alicia ^a   Alvarez, Asuncion ^a   Caorsi, Hena ^a   Drücke, Tilman ^b,c   Ambrosoni, Pablo ^a  

^a HOSPITAL DE CLÍNICAS   (Uruguay)

^b INSERM   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Haemodialysis; Hyperparathyroidism; Imaging; Parathyroid scintigraphy; Parathyroidectomy; Sestamibi

Indexed keywords

CALCITRIOL; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PARATHYROID HORMONE;

ADULT; ARTICLE; FEMALE; HEMODIALYSIS PATIENT; HEMODYNAMICS; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID SCINTISCANNING; PARATHYROIDECTOMY; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; UREMIA;

EID: 0033930701     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.8.1201     Document Type: Article

References (21)

1. Drüeke T. The pathogenesis of parathyroid gland hyperplasia in chronic renal failure (Nephrology Forum). Kidney Int 1995; 48: 259-272
2. Parfitt AM. The hyperparathyroidism of chronic renal failure: a disorder of growth. Kidney Int 1997; 52: 3-9
3. Arnold A, Brown MF, Ureña P, Gaz RD, Sarfati E, Drüeke TB. Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 1995; 95: 2047-2054
4. Tominaga Y, Kohara S. Namii Y et al. Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism. World J Surg 1996; 20: 744-752
5. Ishibashi M, Nishida H, Hiromatsu Y, Kojima K, Tabuchi E, Hayabuchi N. Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands. J Nucl Med 1998; 39: 320-324
6. Fukagawa M, Kitaoka M, Inazawa T, Kurokawa K. Imaging of the parathyroid in chronic renal failure: diagnostic and therapeutic aspects. Curr Opin Nephrol Hypertens 1997; 6: 349-355
7. Carvalho PA, Chi ML, Kronauge JF et al. Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts. J Nucl Med 1992; 33: 1516-1521
8. Taillefer R, Boucher Y, Potvin C, Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study). J Nucl Med 1992; 33: 1801-1807
9. 99mTc-sestamibi scintigraphy as a first-line imaging procedure in the preoperative evaluation of hyperparathyroidism. Clin Endocrinol 1995; 43: 525-530
10. Johnston LB, Carrol MJ, Britton KE et al. The accuracy of parathyroid gland localization in primary hyperparathyroidism using sestamibi radionuclide imaging. J Clin Endocrinol Metab 1996; 81: 346-352
11. Casas AT, Burke GJ, Sathyanarayana, Mansberger AR, Wei JP. Prospective comparison of technetium-99m-sestamibi/iodine-123 radionuclide scan versus high-resolution ultrasonography for the preoperative localization of abnormal parathyroid glands in patients with previously unoperated primary hyperparathyroidism. Am J Surg 1993; 166: 369-373
12. Adalet I, Hawkins T, Clark F, Wilkinson R. Thallium-technetium-subtraction scintigraphy in secondary hyperparathyroidism. Eur J Nucl Med 1994; 21: 509-513
13. Piga M, Bolasco P, Satta L et al. Double-phase parathyroid technetium-99m-MIBI scintigraphy to identify functional autonomy in secondary hyperparathyroidism. J Nucl Med 1996; 37: 565-569
14. 99mTc-sestamibi subtraction SPECT in hyperparathyroidism. Am J Roentgenol 1997; 169: 1671-1674
15. McCarron DA, Lenfesty B, Narasimhan N, Barry JM, Vetto RM, Bennett WM. Anatomical heterogeneity of parathyroid glands in posttransplant hyperparathyroidism. Am J Nephrol 1988; 8: 388-391
16. Borrego MJ, Felsenfeld AJ, Martin-Malo A et al. Evidence for adaptation of the entire PTH-calcium curve to sustained changes in the serum calcium in haemodialysis patients. Nephrol Dial Transplant 1997; 12: 505-513
17. Goodman WG, Veldhuis JD, Belin TR, VanHerle AJ, Jüppner H, Salusky IB. Calcium-sensing by parathyroid glands in secondary hyperparathyroidism. J Clin Endocrinol Metab 1998; 83: 2765-2772
18. Vallabhaneni VR, Chiu ML, Kronauge JF, Piwnica-Worms D. Expression of recombinant human multidrug resistance P-glycoprotein in insect cells confers decreased accumulation of technetium-99m-sestamibi. J Nucl Med 1994; 35: 510-515
19. Axiotis CA, Bani D, Pioll P, Tanin A, Brani ML. P-glycoprotein is expressed in parathyroid epithelium and is regulated by calcium. Calcif Tissue Int 1995; 56: 170-174
20. Canella G, Bonucci E, Rolla D et al. Evidence of healing of secondary hyperparathyroidism in chronically hemodialyzed uremic patients treated with long-term intravenous calcitriol. Kidney Int 1994; 46: 1124-1132
21. Hindie E, Ureña P, Jeanguillaume C et al. Preoperative imaging of parathyroid glands with technetium-99m-labelled sestamibi and iodine-123 subtraction scanning in secondary hyperparathyroidism. Lancet 1999; 353: 2200-2204